Press Releases

Augmedix to Report 2021 First Quarter Financial Results on May 13, 2021

Augmedix, a leading provider of remote medical documentation and live clinical support, has announced that it will report financial results for the first quarter 2021 on Thursday, May 13, 2021, after market close. Company management will host a corresponding conference call at 1:30 p.m. PT / 4:30 p.m. ET. The conference call can be accessed by dialing +1 (877) 407-3982 for U.S. participants, or +1 (201) 493-6780 for international participants. Use conference ID #13719307 to log into the call. Interested parties may access a live and...

Pharmapacks Announces Expansion and Reformation of Board of Directors and Advisors

Pharmapacks, an eCommerce enablement platform and retail seller for brands across major eCommerce marketplaces, announced that it has a new Board of Directors and Advisors, effective January 2021. The announcement follows Pharmapacks’ partnership with and strategic investment from The Carlyle Group in November of 2020. The Board of Directors and Advisors is composed of 10 members: Andrew Vagenas, Pharmapacks Founder and CEO and Chairman of the Board of Directors and Advisors Jay Simmons, Managing Director, Head of Global Consumer, Media, and Retail, The Carlyle Group Yue...

Accolade to Acquire PlushCare

Accolade announced that it has signed a definitive agreement to acquire PlushCare, a leading provider of virtual primary care and mental health treatment. Together, the two companies intend to provide more seamless consumer access to care for acute, chronic, and preventative health needs, whether delivered virtually with PlushCare or through Accolade’s advocacy and navigation solutions that support in-person consultation. The addition of a primary care team will extend Accolade’s ability to improve clinical health outcomes for its members and deliver additional cost savings for employers. “Healthcare...

Aledade Announces Carbon Neutrality, Additional Sustainability Efforts

On Earth Day 2021, Aledade announced three key sustainability commitments the company is making in an effort to reduce its carbon footprint and support a healthier environment. First among them, Aledade announced that, effective immediately, the company is carbon-neutral and will ensure the offset of any carbon emissions that cannot be reduced. All of the company’s emissions in the first quarter of 2021 will be offset by permanently destroying refrigerant chemicals containing chlorofluorocarbons. “The health of our environment directly impacts the health of our populations, and...

Evidation Partners with HealthVerity to Enhance its Research and Virtual Health Offerings

Evidation and HealthVerity have announced a collaboration to provide greater transparency to the patient experience by allowing individuals to connect their wearable and survey data with real-world data from clinical settings via HealthVerity. The partnership will enable researchers and developers of health programs to be more responsive to individuals’ unique health considerations, correlating activities, behaviors, and outcomes in real life with data from clinical settings. Based on per-use consent, people can choose to share electronic medical records, medical and pharmacy claims, and lab data, along with...

Clinical Ink Deploys eCOA Solutions for Industry’s Most Complex Assessments

Global clinical trial technology company Clinical Ink announced that it has deployed an industry-leading 500 unique eCOA scales and assessments in 82 languages. eCOA, or electronic clinical outcome assessment, instruments play a critical role in clinical trial conduct and are used in a variety of ways, from screening for inclusion to use as a primary endpoint. The complex eCOA scales and assessments solutions Clinical Ink is offering include the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), Vineland-3, Bayley-III, and others that have never been...

Health Care Transformation Task Force Expands its Executive Committee

Aledade Chief Commercial Officer and Chief Policy Officer Sean Cavanaugh is one of five people recently elected to the Executive Committee of the Health Care Transformation Task Force. The Health Care Transformation Task Force (HCTTF) is a group of leading payers, providers, purchasers, and patient advocacy organizations working to lead the transformation of the healthcare system from a fee-for-service model to a value-based model. The other new members of the Executive Committee are Jordan Asher, executive vice president and chief physician executive at Sentara Healthcare; Andrea Boudreaux,...

Accolade to Announce Fiscal Fourth Quarter and Full Year 2021 Financial Results

Accolade, which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, announced that it will release fiscal fourth quarter and full year 2021 financial results on Wednesday, May 5, 2021, after the market closes. In conjunction with the release, Accolade will host a conference call to review results at 4:30 p.m. ET on the same day. The conference call can be accessed by dialing 1-8733-519-1281 for U.S. participants, or 1-914-800-3853 for international participants, referencing conference ID #2082409,...

Evidation Raises $153 Million to Scale Virtual Health Capabilities of Achievement™ Platform

Evidation Health today announced the close of a $153 million Series E growth funding round to rapidly expand its virtual health programs on Achievement, the largest digital health network in the United States. The round was co-led by OMERS Growth Equity and Kaiser Permanente Group Trust; existing investors including McKesson Ventures and B Capital group also participated. Evidation will use this additional capital to fuel the expansion of virtual health programs on its privacy-forward Achievement platform, building on its trusted relationships with individuals and its experience...

CD&R, Merck, and McKesson Ventures Invest in Innovative Oncology Data and Informatics Platform

Oncology data and informatics platform M2GEN has announced a significant investment by three major venture investment firms: Clayton, Dubilier & Rice (CD&R), Merck Global Health Innovation Fund (Merck GHI), and McKesson Ventures. The investment will recapitalize M2GEN to accelerate the growth of M2GEN’s clinicogenomic data asset and advance the company’s technology and informatics capabilities. The terms of the transaction were not disclosed. McKesson Ventures and Merck GHI invested alongside CD&R funds, now the company’s largest shareholders. Existing shareholders Moffitt Cancer Center, Hearst, and Ohio State Foundation...